- Open access
- Published:
A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters
Biological Procedures Online volume 10, pages 90–101 (2008)
Abstract
The present study describes a protocol to generate heterogenous populations of neurotransmitter-producing neurons from human mesenchymal stem cells (MSCs). MSCs are bone marrow (BM)-derived cells which undergo lineage-specific differentiation to generate bone, fat, cartilage and muscle, but are also capable of transdifferentiating into defined ectodermal and endodermal tissues. The purpose of this study is to evaluate the potential of MSCs as an alternative source of customized neurons for experimental neurobiology or other regenerative approaches. Our neuronal protocol utilizes freshly harvested human MSCs cultured on specific surfaces and exposed to an induction cocktail consisting of low serum concentration, retinoic acid (RA), growth factors and supplements. Here we report on the types of neurotransmitters produced by the neurons, and demonstrate that the cells are electrically responsive to exogenous neurotransmitter administration.
References
Korecka JA, Verhaagen J, Hol EM. Cell-replacement and gene-therapy strategies for Parkinson’s and Alzheimer’s disease. Regen Med 2007; 2:425–446.
Silani V, Corbo M. Cell-replacement therapy with stem cells in neurodegenerative diseases. Curr Neurovasc Res 2004; 1:283–289.
Kocher AA, Schlechta B, Gasparovicova A, Wolner E, Bonaros N, Laufer G. Stem cells and cardiac regeneration. Transpl Int 2007; 20:731–746.
Lock LT, Tzanakakis ES. Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng 2007; 13:1399–1412.
Scheffler B, Edenhofer F, Brüstle O. Merging fields: stem cells in neurogenesis, transplantation, and disease modeling. Brain Pathol 2006; 16:155–168.
Lensch MW, Daley GQ. Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells. Blood 2006; 107:2605–2612.
Ho HY, Li M. Potential application of embryonic stem cells in Parkinson’s disease: drug screening and cell therapy. Regen Med 2006; 1:175–182.
Horrocks C, Halse R, Suzuki R, Shepherd PR. Human cell systems for drug discovery. Curr Opin Drug Discov Devel 2003; 6:570–575.
Cho KJ, Trzaska KA, Greco SJ, McArdle J, Wang FS, Ye JH, Rameshwar P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 2005; 23:383–391.
Greco SJ, Zhou C, Ye JH, Rameshwar P. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 2007; 16:811–826.
Trzaska KA, Kuzhikandathil EV, Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 2007; 25:2797–2808.
Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19:180–192.
Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28:875–884.
Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004; 32:414–425.
Greco SJ, Liu K, Rameshwar P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 2007; 25:3143–3154.
Jeon SJ, Oshima K, Heller S, Edge AS. Bone marrow mesenchymal stem cells are progenitors in vitro for inner ear hair cells. Mol Cell Neurosci 2007; 34:59–68.
Eberhardt M, Salmon P, von Mach MA, Hengstler JG, Brulport M, Linscheid P, Seboek D, Oberholzer D, Barbero A, Martin I, Muller B, Trono D, Zulewski H. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun 2006; 345:1167–1176.
Choi KS, Shin JS, Lee JJ, Kim YS, Kim SB, Kim CW. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 2005; 330:1299–1305.
Ong SY, Dai H, Leong KW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials 2006; 27:4087–4097.
Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P. Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003; 171:3426–3434.
Hasselmo ME. Neuromodulation and cortical function: Modeling the physiological basis of behavior. Behav Brain Res 1995; 67:1–27.
Möhler H, Fritschy JM, Crestani F, Hensch T, Rudolph U. Specific GABA(A) circuits in brain development and therapy. Biochem Pharmacol 2004; 68:1685–1690.
Greco SJ, Corcoran KE, Cho KJ, Rameshwar P. Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci 2004; 9:1782–1793.
Greco SJ, Rameshwar P. Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. J Immunol 2007; 179:3342–3350.
Ma QP, Hill R, Sirinathsinghji D. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci 2001; 13:2099–2104.
Greco SJ, Rameshwar P. miRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci USA 2007; 104:15484–15489.
Ganea D, Gonzalez-Rey E, Delgado M. A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. J Neuroimmune Pharmacol 2006; 1:400–409.
Castillo MD, Trzaska KA, Greco SJ, Ponzio NM, Rameshwar P. Immunostimulatory effects of mesenchymal stem cell-derived neurons: Implications for stem cell therapy in allogeneic transplantations. Clin Transl Sci 2008;1:27–34.
Shigematsu N, Yamamoto K, Higuchi S, Fukuda T. An immunohistochemical study on a unique colocalization relationship between substance P and GABA in the central nucleus of amygdala. Brain Res 2008; 1198C:55–67.
Tan CO, Bullock D. Neuropeptide co-release with GABA may explain functional non-monotonic uncertainty responses in dopamine neurons. Neurosci Lett 2008; 430:218–223.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Greco, S.J., Zhou, C., Ye, JH. et al. A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters . Biol. Proced. Online 10, 90–101 (2008). https://doiorg.publicaciones.saludcastillayleon.es/10.1251/bpo147
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1251/bpo147